Global Nosocomial Infection Treatment Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Nosocomial Infection Treatment Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Antibacterial Treatment
- 1.4.3 Antiviral Treatment
- 1.4.4 Antifungal Treatment
- 1.5 Market by Application
- 1.5.1 Global Nosocomial Infection Treatment Market Share by Application (2019-2025)
- 1.5.2 Ventilator Associated Pneumonia
- 1.5.3 Urinary Tract Infection
- 1.5.4 Blood Stream Infection
- 1.5.5 Surgical Site Infection
- 1.5.6 Gastrointestinal Infection
- 1.5.7 MRSA
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Nosocomial Infection Treatment Market Size
- 2.2 Nosocomial Infection Treatment Growth Trends by Regions
- 2.2.1 Nosocomial Infection Treatment Market Size by Regions (2019-2025)
- 2.2.2 Nosocomial Infection Treatment Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Nosocomial Infection Treatment Market Size by by Players
- 3.1.1 Global Nosocomial Infection Treatment Revenue by by Players (2014-2019)
- 3.1.2 Global Nosocomial Infection Treatment Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Nosocomial Infection Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Nosocomial Infection Treatment Key Players Head office and Area Served
- 3.3 Key Players Nosocomial Infection Treatment Product/Solution/Service
- 3.4 Date of Enter into Nosocomial Infection Treatment Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Nosocomial Infection Treatment Market Size by Type (2014-2019)
- 4.2 Global Nosocomial Infection Treatment Market Size by Application (2014-2019)
5 North America
- 5.1 North America Nosocomial Infection Treatment Market Size (2014-2019)
- 5.2 Nosocomial Infection Treatment Key Players in North America
- 5.3 North America Nosocomial Infection Treatment Market Size by Type
- 5.4 North America Nosocomial Infection Treatment Market Size by Application
6 Europe
- 6.1 Europe Nosocomial Infection Treatment Market Size (2014-2019)
- 6.2 Nosocomial Infection Treatment Key Players in Europe
- 6.3 Europe Nosocomial Infection Treatment Market Size by Type
- 6.4 Europe Nosocomial Infection Treatment Market Size by Application
7 China
- 7.1 China Nosocomial Infection Treatment Market Size (2014-2019)
- 7.2 Nosocomial Infection Treatment Key Players in China
- 7.3 China Nosocomial Infection Treatment Market Size by Type
- 7.4 China Nosocomial Infection Treatment Market Size by Application
8 Japan
- 8.1 Japan Nosocomial Infection Treatment Market Size (2014-2019)
- 8.2 Nosocomial Infection Treatment Key Players in Japan
- 8.3 Japan Nosocomial Infection Treatment Market Size by Type
- 8.4 Japan Nosocomial Infection Treatment Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Nosocomial Infection Treatment Market Size (2014-2019)
- 9.2 Nosocomial Infection Treatment Key Players in Southeast Asia
- 9.3 Southeast Asia Nosocomial Infection Treatment Market Size by Type
- 9.4 Southeast Asia Nosocomial Infection Treatment Market Size by Application
10 India
- 10.1 India Nosocomial Infection Treatment Market Size (2014-2019)
- 10.2 Nosocomial Infection Treatment Key Players in India
- 10.3 India Nosocomial Infection Treatment Market Size by Type
- 10.4 India Nosocomial Infection Treatment Market Size by Application
11 Central & South America
- 11.1 Central & South America Nosocomial Infection Treatment Market Size (2014-2019)
- 11.2 Nosocomial Infection Treatment Key Players in Central & South America
- 11.3 Central & South America Nosocomial Infection Treatment Market Size by Type
- 11.4 Central & South America Nosocomial Infection Treatment Market Size by Application
12 International Players Profiles
- 12.1 Abbott
- 12.1.1 Abbott Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Nosocomial Infection Treatment Introduction
- 12.1.4 Abbott Revenue in Nosocomial Infection Treatment Business (2014-2019))
- 12.1.5 Abbott Recent Development
- 12.2 Bayer
- 12.2.1 Bayer Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Nosocomial Infection Treatment Introduction
- 12.2.4 Bayer Revenue in Nosocomial Infection Treatment Business (2014-2019)
- 12.2.5 Bayer Recent Development
- 12.3 Becton, Dickinson and Company
- 12.3.1 Becton, Dickinson and Company Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Nosocomial Infection Treatment Introduction
- 12.3.4 Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2014-2019)
- 12.3.5 Becton, Dickinson and Company Recent Development
- 12.4 Belimed
- 12.4.1 Belimed Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Nosocomial Infection Treatment Introduction
- 12.4.4 Belimed Revenue in Nosocomial Infection Treatment Business (2014-2019)
- 12.4.5 Belimed Recent Development
- 12.5 BioMerieux
- 12.5.1 BioMerieux Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Nosocomial Infection Treatment Introduction
- 12.5.4 BioMerieux Revenue in Nosocomial Infection Treatment Business (2014-2019)
- 12.5.5 BioMerieux Recent Development
- 12.6 Cantel
- 12.6.1 Cantel Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Nosocomial Infection Treatment Introduction
- 12.6.4 Cantel Revenue in Nosocomial Infection Treatment Business (2014-2019)
- 12.6.5 Cantel Recent Development
- 12.7 Cepheid
- 12.7.1 Cepheid Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Nosocomial Infection Treatment Introduction
- 12.7.4 Cepheid Revenue in Nosocomial Infection Treatment Business (2014-2019)
- 12.7.5 Cepheid Recent Development
- 12.8 Getinge Group
- 12.8.1 Getinge Group Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Nosocomial Infection Treatment Introduction
- 12.8.4 Getinge Group Revenue in Nosocomial Infection Treatment Business (2014-2019)
- 12.8.5 Getinge Group Recent Development
- 12.9 Kimberly-Clark Corp.
- 12.9.1 Kimberly-Clark Corp. Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Nosocomial Infection Treatment Introduction
- 12.9.4 Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2014-2019)
- 12.9.5 Kimberly-Clark Corp. Recent Development
- 12.10 Merck & Co
- 12.10.1 Merck & Co Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Nosocomial Infection Treatment Introduction
- 12.10.4 Merck & Co Revenue in Nosocomial Infection Treatment Business (2014-2019)
- 12.10.5 Merck & Co Recent Development
- 12.11 Nordion
- 12.12 Pfizer
- 12.13 Roche
- 12.14 Sakura Seiki
- 12.15 BioMérieux
- 12.16 Steris
- 12.17 Johnson & Johnson
- 12.18 Sterigenics International, Inc.
- 12.19 Halyard Health, Inc.
- 12.20 Advanced Sterilization Products
- 12.21 Matachana Group
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Nosocomial infection, also known as hospital acquired or associated infection (HAI) is defined as an infection developed in patients during the hospital stay that was earlier not present or incubated during admission in the hospital.
In 2018, the global Nosocomial Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Nosocomial Infection Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nosocomial Infection Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott
Bayer
Becton, Dickinson and Company
Belimed
BioMerieux
Cantel
Cepheid
Getinge Group
Kimberly-Clark Corp.
Merck & Co
Nordion
Pfizer
Roche
Sakura Seiki
BioMérieux
Steris
Johnson & Johnson
Sterigenics International, Inc.
Halyard Health, Inc.
Advanced Sterilization Products
Matachana Group
Market segment by Type, the product can be split into
Antibacterial Treatment
Antiviral Treatment
Antifungal Treatment
Market segment by Application, split into
Ventilator Associated Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
Gastrointestinal Infection
MRSA
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Nosocomial Infection Treatment status, future forecast, growth opportunity, key market and key players.
To present the Nosocomial Infection Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Nosocomial Infection Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.